This combination may also overcome resistance to CTLA-4 blockade mediated by tumor PD-L1 expression or resistance to PD-1 blockade mediated by T-cell downregulation through the coexpression of CTLA-4. The gene discussed is PDCD1; the disease is neoplasm.